Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.545
-0.035 (-2.22%)
At close: May 11, 2026, 4:00 PM EDT
1.530
-0.015 (-0.97%)
After-hours: May 11, 2026, 4:10 PM EDT
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $197.18 million as of May 11, 2026. Its market cap has increased by 25.52% in one year.
Market Cap
197.18M
Enterprise Value
191.71M
1-Year Change
25.52%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $197.18M, an increase of 35.09%. That is a compound annual growth rate of 6.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 201.65M | 13.89% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 217.00M |
| MediWound | 212.96M |
| Atrium Therapeutics | 202.78M |
| Unicycive Therapeutics | 200.39M |
| Tonix Pharmaceuticals Holding | 200.15M |
| Precision BioSciences | 198.43M |
| Whitehawk Therapeutics | 196.23M |
| Karyopharm Therapeutics | 194.77M |